Cart
sales@molnova.com
M7594_0037
CAS No. 774551-07-4
M7594_0037( —— )
Catalog No. M34330 CAS No. 774551-07-4
M7594_0037 is an inhibitor of Human peptide deformylase (HsPDF) and can be used in studies about anticancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | Get Quote |
|
| 5MG | 256 | Get Quote |
|
| 10MG | 375 | Get Quote |
|
| 25MG | 545 | Get Quote |
|
| 50MG | 762 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 200MG | 1368 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameM7594_0037
-
NoteResearch use only, not for human use.
-
Brief DescriptionM7594_0037 is an inhibitor of Human peptide deformylase (HsPDF) and can be used in studies about anticancer.
-
DescriptionM7594_0037 is a potent inhibitor of human peptide deformylase (HsPDF) that has anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number774551-07-4
-
Formula Weight387.86
-
Molecular FormulaC20H22ClN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(CNCCC2=CNC3=CC=CC=C23)=CC(Cl)=C1OCC(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jian Gao, et al. Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer. Molecules. 2016 Mar 23;21(4):396.?
molnova catalog
related products
-
4,6,3',4'-Tetrahydro...
4,6,3',4'-Tetrahydroxyaurone is a flavonoid from the herbs of Heleocharis dulcis.
-
Caesappanin C
Caesappanin C, extracted from the heartwood of Indonesian Caesalpinia sappan L., shows strong proliferation stimulating activity against the primary osteoblastic cells in vitro.
-
Dihydrotachysterol
Dihydrotachysterol (HSDB 3314) is a vitamin D analog.Dihydrotachysterol has been used to study hypocalcemic hypoparathyroidism after surgical removal of the parathyroid glands and growth impairment in children with chronic renal insufficiency.
